Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Alleviation of Upper Respiratory Inflammation and Associated Common Cold Symptoms

NCT06106880 is registered in ClinicalTrials.gov with Applied Biological Laboratories Inc as lead sponsor.

NCT NCT06106880
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06106880 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Alleviation of Upper Respiratory Inflammation and Associated Common Cold Symptoms
Lead sponsor
Applied Biological Laboratories Inc
Phase
Phase 1
Overall status
Completed
Start date
May 25, 2022
Completion date
June 16, 2023
Enrollment
157 (actual)
Sites
6

Conditions

As the registry lists them; a condition with its own page is linked.

common cold, congestion, cough, fever, headache, malaise, pharyngitis, rhinorrhea, runny nose, sneezing, sore throats viral, sore-throat